ELVN SCHEDULE 13G/A: SEC filing
Enliven Therapeutics, Inc.
Filed with the SEC on · accession 0002012383-26-003776
ELVN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 27, 2026. Enliven Therapeutics, Inc. filed an amended Schedule 13G (SCHEDULE 13G/A) indicating a change in a passive holder's ownership position. The stock moved +5.3% by the first close after the filing.
Summary of the filing
Enliven Therapeutics, Inc. filed an amended Schedule 13G (SCHEDULE 13G/A) indicating a change in a passive holder's ownership position. The filing does not disclose a specific corporate event.
Key details
How ELVN stock reacted
Close before
$41.49
Oct 26, 2026
First close after
+5.30%
$43.69
5 trading days
+7.57%
$44.63
Since filing
+19.14%
$49.43
✦ Ask GOAX AI about this filing — what it means for ELVN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ELVN?
Click hereFrequently asked questions
What did ELVN file with the SEC on Oct 27, 2026?
ELVN filed a SCHEDULE 13G/A (SEC filing). Enliven Therapeutics, Inc. filed an amended Schedule 13G (SCHEDULE 13G/A) indicating a change in a passive holder's ownership position. The filing does not disclose a specific corporate event.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did ELVN stock react to this filing?
ELVN closed at $41.49 before the filing and $43.69 on Oct 27, 2026 (+5.30%). Five trading days later: $44.63 (+7.57%).
Other ELVN SEC filings
- 8-K · SEC filingNov 5, 2026
- 10-Q · SEC filingNov 5, 2026
- 8-K · Board changeOct 14, 2026
- 8-K · SEC filingAug 5, 2026
- 10-Q · SEC filingAug 5, 2026
- 144 · Insider sale plannedJun 22, 2026
- 144 · Insider sale plannedJun 22, 2026
- 144 · Insider sale plannedJun 22, 2026
- 144 · Insider sale plannedJun 17, 2026
- 144 · Insider sale plannedJun 15, 2026
Get alerts when ELVN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days